Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis
Saved in:
| Published in: | Thoracic Cancer |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1870387948995739648 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Thoracic Cancer |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:101823 |
| institution | FRELIP |
| journal_source_facet | Thoracic Cancer |
| last_indexed | 2026-07-11T03:35:48.553Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis |
| title_alt | RETRACCIÓN: Delanzomib, un nuevo inhibidor del proteasoma, sensibiliza las células de cáncer de mama a la apoptosis inducida por doxorrubicina RÉTRACTATION : Le delanzomib, un nouvel inhibiteur du protéasome, sensibilise les cellules de cancer du sein à l'apoptose induite par la doxorubicine RETRATAÇÃO: Delanzomibe, um Novo Inibidor de Proteassoma, Sensibiliza Células de Câncer de Mama à Apoptose Induzida por Doxorrubicina |
| title_auth | RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis |
| title_es_txt | RETRACCIÓN: Delanzomib, un nuevo inhibidor del proteasoma, sensibiliza las células de cáncer de mama a la apoptosis inducida por doxorrubicina |
| title_fr_txt | RÉTRACTATION : Le delanzomib, un nouvel inhibiteur du protéasome, sensibilise les cellules de cancer du sein à l'apoptose induite par la doxorubicine |
| title_full | RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis |
| title_fullStr | RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis |
| title_full_unstemmed | RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis |
| title_pt_txt | RETRATAÇÃO: Delanzomibe, um Novo Inibidor de Proteassoma, Sensibiliza Células de Câncer de Mama à Apoptose Induzida por Doxorrubicina |
| title_short | RETRACTION: Delanzomib, a Novel Proteasome Inhibitor, Sensitizes Breast Cancer Cells to Doxorubicin‐Induced Apoptosis |
| title_sort | retraction: delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin‐induced apoptosis |
| topic | Oncology General Oncology |
| url | https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.70346?af=R |